A new tool to study ribavirin-induced haemolysisBROCHOT, Etienne; FRANCOIS, Catherine; CASTELAIN, Sandrine et al.Antiviral therapy (London). 2012, Vol 17, Num 7, pp 1311-1317, issn 1359-6535, 7 p.Article

Antiviral activity of nucleoside analogues against norovirusCOSTANTINI, Verónica P; WHITAKER, Tony; BARCLAY, Leslie et al.Antiviral therapy (London). 2012, Vol 17, Num 6, pp 981-991, issn 1359-6535, 11 p.Article

Clofarabine as a potential stimulant of alloreactivityATIMERE, N; ZRIBA, S; HICHERI, Y et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 10, pp 1393-1394, issn 0268-3369, 2 p.Article

Ribavirin Enhances Interferon-Stimulated Gene Transcription by Activation of the Interferon-Stimulated Response ElementQIUWEI PAN; TILANUS, Hugo W; JANSSEN, Harry L. A et al.Hepatology (Baltimore, Md.). 2011, Vol 53, Num 4, pp 1400-1401, issn 0270-9139, 2 p.Article

Presumed entecavir-induced ocular toxicityMUQIT, Mkm; STANGA, P. E; VILAR, F. J et al.Eye (London. 1987). 2011, Vol 25, Num 12, pp 1665-1668, issn 0950-222X, 4 p.Article

Lethal Mutagenesis of Picornaviruses with N-6-Modified Purine Nucleoside AnaloguesGRACI, Jason D; TOO, Kathleen; BROWN, Daniel M et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 3, pp 971-979, issn 0066-4804, 9 p.Article

Virologic Characterization of Multidrug-Resistant Cytomegalovirus Infection in 2 Transplant Recipients Treated with MaribavirSTRASFELD, Lynne; LEE, Ingi; TATAROWICZ, Walter et al.The Journal of infectious diseases. 2010, Vol 202, Num 1, pp 104-108, issn 0022-1899, 5 p.Article

Macromolecular Prodrugs of Ribavirin: Concerted Efforts of the Carrier and the DrugSMITH, Anton A. A; WOHL, Benjamin M; KRYGER, Mille B. L et al.Advanced healthcare materials (Print). 2014, Vol 3, Num 9, pp 1404-1407, issn 2192-2640, 4 p.Article

Infections During Peginterferon/Ribavirin Therapy Are Associated With the Magnitude of Decline in Absolute Lymphocyte Count: Results of the IDEAL StudyMELIA, Michael T; BRÄU, Norbert; SCHIFF, Eugene et al.Clinical infectious diseases. 2014, Vol 58, Num 7, pp 960-969, issn 1058-4838, 10 p.Article

Unraveling the genetic predisposition of ribavirin-induced anaemiaASSELAH, Tarik; PASMANT, Eric; LYOUMI, Said et al.Journal of hepatology. 2010, Vol 53, Num 5, pp 971-973, issn 0168-8278, 3 p.Article

KAY-2-41, a Novel Nucleoside Analogue Inhibitor of Orthopoxviruses In Vitro and In VivoDURAFFOUR, Sophie; DRILLIEN, Robert; HARAGUCHI, Kazuhiro et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 1, pp 27-37, issn 0066-4804, 11 p.Article

Treatment of HCV with ABT-450/r- Ombitasvir and Dasabuvir with RibavirinFELD, Jordan J; KOWDLEY, Kris V; DASILVA-TILLMANN, Barbara et al.The New England journal of medicine. 2014, Vol 370, Num 17, pp 1594-1603, issn 0028-4793, 10 p.Article

Pegylated interferon plus ribavirin is suboptimal in IL28B CC carriers without rapid responseNEUKAM, Karin; BARREIRO, Pablo; RIVERO-JUAREZ, Antonio et al.The Journal of infection. 2013, Vol 67, Num 1, pp 59-64, issn 0163-4453, 6 p.Article

Long-term glucose tolerance in highly experienced HIV-infected patients receiving nucleoside analogue-sparing regimensBIGOLONI, Alba; GIANOTTI, Nicola; LAZZARIN, Adriano et al.AIDS (London). 2012, Vol 26, Num 14, pp 1837-1840, issn 0269-9370, 4 p.Article

Pharmacokinetics, safety, and tolerability of ribavirin in hemodialysis-dependent patientsGUPTA, Samir K; KANTESARIA, Bhavna; GLUE, Paul et al.European journal of clinical pharmacology. 2012, Vol 68, Num 4, pp 415-418, issn 0031-6970, 4 p.Article

Excision of nucleoside analogs in mitochondria by p53 proteinBAKHANASHVILI, Mary; GRINBERG, Shai; BONDA, Elad et al.AIDS (London). 2009, Vol 23, Num 7, pp 779-788, issn 0269-9370, 10 p.Article

Clevudine is efficiently phosphorylated to the active triphosphate form in primary human hepatocytesCONGRONG NIU; MURAKAMI, Eisuke; FURMAN, Phillip A et al.Antiviral therapy (London). 2008, Vol 13, Num 2, pp 263-269, issn 1359-6535, 7 p.Article

Stimulation of Suicidal Erythrocyte Death by RibavirinOSWALD, Gergely; ALZOUBI, Kousi; ABED, Majed et al.Basic & clinical pharmacology & toxicology (Print). 2014, Vol 114, Num 4, pp 311-317, issn 1742-7835, 7 p.Article

Conformational Freedom in Tight Binding Enzymatic Transition-State AnaloguesMOTLEY, Matthew W; SCHRAMM, Vern L; SCHWARTZ, Steven D et al.The Journal of physical chemistry. B. 2013, Vol 117, Num 33, pp 9591-9597, issn 1520-6106, 7 p.Article

An Adaptive Randomized Trial of an Intermittent Dosing Schedule of Aerosolized Ribavirin in Patients With Cancer and Respiratory Syncytial Virus InfectionCHEMALY, Roy F; TORRES, Harrys A; MUNSELL, Mark F et al.The Journal of infectious diseases. 2012, Vol 206, Num 9, pp 1367-1371, issn 0022-1899, 5 p.Article

Suivi thérapeutique pharmacologique de la ribavirine = Therapeutic drug monitoring of ribavirinSALAS, C; STANKE-LABESQUE, F.La Lettre de l'infectiologue. 2012, Vol 27, Num 2, pp 74-80, issn 0296-9009, 7 p.Article

Peginterferon With or Without Ribavirin Has Minimal Effect on Quality of Life, Behavioral/Emotional, and Cognitive Outcomes in ChildrenRODRIGUE, James R; BALISTRERI, William; LOBRITTO, Steven J et al.Hepatology (Baltimore, Md.). 2011, Vol 53, Num 5, pp 1468-1475, issn 0270-9139, 8 p.Article

Peginterferon Plus Ribavirin and Sustained Virological Response in HCV-Related Cirrhosis: Outcomes and Factors Predicting ResponseFERNANDEZ-RODRIGUEZ, Conrado M; ALONSO, Sonia; FERNANDEZ, Inmaculada et al.The American journal of gastroenterology. 2010, Vol 105, Num 10, pp 2164-2172, issn 0002-9270, 9 p.Article

Ribavirin therapeutic drug monitoring: why, when and how?STANKE-LABESQUE, Françoise; LOUSTAUD-RATTI, Véronique; BABANY, Gérard et al.Fundamental & clinical pharmacology. 2010, Vol 24, Num 4, pp 401-406, issn 0767-3981, 6 p.Article

Serum Cholesterol and Statin Use Predict Virological Response to Peginterferon and Ribavirin TherapyHARRISON, Stephen A; ROSSARO, Lorenzo; BRASS, Clifford A et al.Hepatology (Baltimore, Md.). 2010, Vol 52, Num 3, pp 864-874, issn 0270-9139, 11 p.Article